Kbc Group Nv Intellia Therapeutics, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,753 shares of NTLA stock, worth $53,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,753

Previous 2,733 37.32%

Holding current value

$53,667

Previous $61,000 26.23%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$19.72 - $27.36 $20,114 - $27,907	1,020 Added 37.32%	3,753 $77,000
Q2 2024 Jul 17, 2024	BUY	$20.02 - $27.22 $18,818 - $25,586	940 Added 52.43%	2,733 $61,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $41,525 - $57,985	1,793 New	1,793 $55,000
Q4 2020 Feb 10, 2021	SELL	$18.83 - $63.53 $19,206 - $64,800	-1,020 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$10.43 - $17.67 $30,664 - $51,949	-2,940 Reduced 74.24%	1,020 $15,000
Q3 2019 Nov 07, 2019	BUY	$13.07 - $18.51 $44,960 - $63,674	3,440 Added 661.54%	3,960 $52,000
Q2 2019 Dec 03, 2019	BUY	$13.88 - $18.41 $7,217 - $9,573	520 New	520 $9,000
Q2 2019 Jul 30, 2019	SELL	$13.88 - $18.41 $7,217 - $9,573	-520 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$12.79 - $17.62 $6,650 - $9,162	520 New	520 $9,000
Q1 2019 May 10, 2019	SELL	$12.79 - $17.62 $3,325 - $4,581	-260 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$11.39 - $27.13 $2,961 - $7,053	260 New	260 $4,000
Q4 2018 Jan 31, 2019	SELL	$11.39 - $27.13 $5,979 - $14,243	-525 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$25.78 - $32.6 $13,534 - $17,115	525 New	525 $14,000
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $13,534 - $17,115	-525 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$20.02 - $30.79 $10,510 - $16,164	525 New	525 $14,000
Q2 2018 Aug 03, 2018	SELL	$20.02 - $30.79 $10,510 - $16,164	-525 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$19.43 - $34.95 $10,200 - $18,348	525 New	525 $11,000
Q1 2018 May 09, 2018	SELL	$19.43 - $34.95 $10,200 - $18,348	-525 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$17.39 - $31.12 $9,129 - $16,338	525	525 $10,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.09B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account